Co-Diagnostics adopts amended bylaws; permits classified board, eliminates written consent

Co-Diagnostics, Inc.

Board adopted amended and restated bylaws effective March 31, 2022.
New bylaws permit creation of a classified board of directors.
Quorum requirement for stockholder meetings reduced; detailed requirements for shareholder proposals and board nominations added.
Shareholder action by written consent eliminated; indemnification of officers and directors allowed.
Full text of amended bylaws filed as Exhibit 3.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.